Compound information
- Natural Products
- ZC2123748
- Molecular Formula
- C17H12N2O3S
- Molecular Weight
- 324.056863244 g/mol
- Structure
-
- IUPAC Name
- (E)-4-[[4-(1-naphthyl)thiazol-2-yl]amino]-4-oxo-but-2-enoic acid
- InChI
- InChI=1S/C17H12N2O3S/c20-15(8-9-16(21)22)19-17-18-14(10-23-17)13-7-3-5-11-4-1-2-6-12(11)13/h1-10H,(H,21,22)(H,18,19,20)/b9-8+
- InChI Key
- IULRPCNAFPDZRM-CMDGGOBGSA-N
- SMILES
- O=C(O)/C=C/C(=O)Nc1nc(-c2cccc3ccccc23)cs1
- Source
- ZINC000000474486
Warheads
- Acrylamide
-
- Acrylate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 79.29 Å2 | LogP | 3.989 |
LogS | -4.818 | LogD | 3.876 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.012 | Pgp substrate | 0.002 |
HIA | 0.844 | F20 % | 0.815 |
F30 % | 0.643 | Caco-2 | -4.628 |
MDCK | -4.846 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.04 | PPB | 100.977 |
VD | 0.294 | Fu | 2.547 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.116 | CYP1A2 substrate | 0.786 |
CYP2A6 substrate | 0.55 | CYP2B6 substrate | 0.695 |
CYP2C19 inhibitor | 0.074 | CYP2C19 substrate | 0.511 |
CYP2C8 substrate | 0.624 | CYP2C9 inhibitor | 0.206 |
CYP2C9 substrate | 0.028 | CYP2D6 inhibitor | 0.115 |
CYP2D6 substrate | 0.315 | CYP2E1 substrate | 0.401 |
CYP3A4 inhibitor | 0.051 | CYP3A4 substrate | 0.845 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.605 | CL | -0.188 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.048 | Hepatotoxicity | 0.747 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.001 |
FDAMDD | 0.148 | Skin Sensitization | 0.578 |
Carcinogenicity | 0.021 | Eye Corrosion | 0.003 |
Eye Irritation | 0.774 | Respiratory Toxicity | 0.542 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.644 | IGC50 | 2.648 |
LC50FM | 5.221 | LC50DM | 4.314 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.523 | NR-AR-LBD | 0.44 |
NR-AhR | 0.969 | NR-Aromatase | 0.041 |
NR-ER | 0.633 | NR-ER-LBD | 0.61 |
NR-PPAR-gamma | 0.899 | SR-ARE | 0.932 |
SR-ATAD5 | 0.85 | SR-HSE | 0.138 |
SR-MMP | 0.966 | SR-p53 | 0.561 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.